Eagle Pharmaceuticals, Inc.
$EGRX
Public valuation for Eagle Pharmaceuticals, Inc. (EGRX). Fair value, signal, and key metrics — no sign-in required.
Current Price
$0.57
3940% Undervalued
Fair Value Estimate
$23
🏛️
Mature Growth
Profitable company with steady growth
Key Metrics
Operating Margin
15.9%
Revenue Growth
-17.5%
Get free watchlist alerts
Join the waitlist for valuation updates on $EGRX and the rest of your watchlist.
Join the waitlistJoin the waitlist
Stay on this page to join — no sign-in required.